PULMATRIX, INC. Warrants and Rights Outstanding
PULMATRIX, INC. (PULM) had Warrants and Rights Outstanding of $0 as of 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2025-08-06
- 2025-06-30: Warrants and Rights Outstanding $0.00.
- 2025-03-31: Warrants and Rights Outstanding $1.00K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |